Peripheral Neuropathies - PowerPoint PPT Presentation

1 / 31
About This Presentation
Title:

Peripheral Neuropathies

Description:

Why payors worry versus why patients worry. Is there a solution? ... This type of neuropathy generally a late finding. Diabetes. Not truly length-dependent ... – PowerPoint PPT presentation

Number of Views:401
Avg rating:3.0/5.0
Slides: 32
Provided by: vhapal3
Category:

less

Transcript and Presenter's Notes

Title: Peripheral Neuropathies


1
Peripheral Neuropathies
  • Jonathan Katz, MD
  • Director Neuromuscular Center
  • CPMC
  • San Francisco, CA

2
The Peripheral Nervous System
  • Motor weakness, atrophy
  • Sensory loss
  • Large Fibers (position)
  • Small fiber (pain)
  • Reflex loss
  • Autonomic symptoms
  • (redness, dizziness, ED)

3
Peripheral Nerve
  • Myelin Current cannot flow
  • Axon Not nerves left

4
Outline
  • Facts about peripheral neuropathies
  • Why is it so hard to diagnose?
  • High Value
  • What is common?
  • What is dangerous?
  • What is responsive to immunotherapy?
  • Cost perspective
  • Why payors worry versus why patients worry
  • Is there a solution?

5
How Common Are Treatable Neuropathies
MAYO CLINIC SOUTHWESTERN MEDICAL CENTER, DALLAS
6
Uncertainty Filter
7
University Filter
8
Pattern Recognition
9
Classification
  • EXAMINATION FINDINGS
  • Purely Motor or Sensory or Sensorimotor?
  • Proximal or distal? Symmetric or asymmetric?
  • Multifocal, generalized, regional?
  • Upper limbs, lower limbs, neck, trunk?
  • TIMING
  • Acute or chronic?
  • ASSOCIATED FINDINGS
  • Painful or painless?
  • Hereditary or sporadic?
  • ELECTRODIAGNOSIS
  • Axonal or demyelinating?
  • LABORATORY
  • Paraprotein present? Type?
  • Antibody against nerve?
  • CSF protein level?
  • HISTOLOGY
  • Inflammatory Cells

10
Chronic Length Dependent Neuropathy
  • Begins in toes or feet
  • Stocking distribution
  • Progresses rostrally
  • Tops and bottoms of feet
  • Weakness begins in ankles when sensation reaches
    calves

Sometimes diagnosable, Never treatable?
11
Laboratory Screening for Treatable Neuropathy?
12
Treatable Cases
CADP
13
Phenotype CIDP
Small Differential
14
Timeline
  • Peter Dyck 1975 a symmetric sensorimotor
    neuropathy with a tendency toward involvement of
    the proximal limb muscles
  • Richard Barohn 1989 exam predicts immune
    responsiveness
  • The era of CIDP criteria

15
Electrodiagnostic Categories
16
Phenotype-MADSAM Neuropathy
  • Sensory and Motor
  • Often painful
  • Hands more than ankles
  • Individual Nerves
  • Stepwise
  • Slowing, CB, TD
  • Prednisone or IVIg (50)

17
Phenotype-MADSAM Neuropathy
  • Key DDx
  • Brachial plexopathies
  • Vasculitic mononeuropathy multiplex
  • Compression neuropathies
  • HNPP (genetic testing)

18
Sensory CIDP
  • Sensory CIDP (Oh et al.)
  • Probably in range of 1/1,000 cases of length
    dependent neuropathy
  • Not length dependent
  • Subacute onset
  • Conduction block
  • Steroid responsive

19
Multifocal Motor Neuropathy (MMN)
  • Almost always in hands and wrists
  • Pattern of weakness is in the distribution of
    individual peripheral nerves
  • i.e. severe involvement in ulnar distribution
    sparing median
  • Lack of atrophy in weak muscles
  • No pathological reflexes

20
Difficult Differential
  • ALS
  • Other Motor Neuron Presentations
  • Chronic Radiculopathy
  • Pinched Nerves (Radial, CTS, Ulnar)
  • 9/18 patients had prior operation
  • Thoracic outlet

21
MMN with Conduction Block
22
Covalink GM1 ELISAHigh-Titer Positive Results
23
Antibodies Length Dependent Neuropathies
DADS-M Neuropathy Distal Acquired Demyelinating
Symmetric Sensory Neuropathy with IgM
Anti-MAG
IgM only
24
  • 10 vs. 2.5

25
Well Defined Immune Disorder?
  • Myelin widening
  • Anti-MAG antibody deposits on myelin
  • Passive transfer model

26
Treatable anti-MAG, IgM neuropathy?
  • Reported Beneficial IVIg, prednisone,
    plasmapheresis, interferon-alpha, rituximab,
    chlorambucil
  • Many reports emphasize a decrease in antibody
    titers
  • Athena Diagnostics Lab Report (with reference)

27
Warning
19 patients 1 sustained response No hematological
deaths 3 treatment deaths 7 others
treatment-related morbidity
28
IVIg Benefit and Cost Perspective
29
IVIg or Prednisone?
  • Responsiveness
  • Costs
  • Frequent infusion, availability of IVIg
  • Side-effects of prednisone
  • Potential serious complications of either drug
  • IVIg in diabetics, renal insufficiency
  • Likelihood of diagnosis
  • Inadequate initial response
  • Patient preferences

30
Uncertainty
  • Many cases are not easily definable because of
    multiplicity of patterns
  • Cases that are not clearly untreatable are
    possibly treatable

31
Costs?
  • 0 Do nothing
  • 15 Prednisone IVIg 75/gram
  • 500 Physical Therapy
  • 3000 Imuran, CellCept, Others
  • 10,000 Pheresis
  • 12000 IVIg
  • Immeasurable Dies from steroids or IVIg
Write a Comment
User Comments (0)
About PowerShow.com